Rebecca D. Jackson, MD
Director, The Center for Clinical and Translational Science
PI, NCATS Clinical and Translational Science Award
376 West 10th Avenue, Suite 260
Columbus, OH 43210
Email Dr. Jackson
Rebecca Jackson, MD, Associate Dean for Clinical Research in the College of Medicine, Professor of Medicine at The Ohio State University, is a well-recognized clinical and translational scientist, involved in collaborative multidisciplinary team science with a focus on the epidemiology of chronic disease in women including osteoporosis and fracture, cardiovascular disease, cancer and osteoarthritis. She has a national presence in translational science through her leadership roles in the national CTSA Consortium Steering Committee, Clinical Research Forum, and NIH Advisory Board for Clinical Research.
She has more than 25 years of NIH funded clinical trials and observational cohort experience with extensive experience and funding in defining biomarkers and genetic associations (through the conduct of GWAS and exome sequencing studies) for sick of cardiovascular disease, fractures, and knee OA. She is currently PI on multiple RC2 and N01 grants, co-investigator on multiple U01, R01 and R21 grants, and is mentor to 2 K awardees. She was vice-chair of the Women’s Health Initiative for more than a decade and currently is PI of the WHI Midwest Regional Field Center.
Jackson was selected to be the first director of The Ohio State University’s Center for Clinical and Translational Science which received CTSA funding in 2008. Since that time she has led the programmatic functions, operations, and strategic planning for the Center in successful development and integration of clinical and translational research infrastructure at OSU.
William E. Smoyer, MD
Vice President for Clinical and Translational Research at NCH
Director of the Center for Clinical and Translational Research at NCH
The Research Institute at Nationwide Children's Hospital
700 Children's Drive
Columbus, OH 43205
Email Dr. Smoyer
For the past 20 years, William E. Smoyer, MD, has focused his career on basic, clinical, and translational research to improve our understanding of the molecular regulation of podocyte injury during nephrotic syndrome, and to develop more targeted and effective novel treatments for childhood nephrotic syndrome.
His work has led to publications in the Journal of Clinical Investigation, FASEB, the Journal of the American Society of Nephrology, as well as several subspecialty journals.
Smoyer oversees the majority of clinical and translational research initiatives by pediatric researchers, and seeks opportunities to integrate pediatrics into all CCTS activities, including education, informatics, translational technologies, research design and implementation programs, and resource allocation. Under his leadership, NCH has expanded its strategic prioritization of clinical and translational research over the last decade, including an extensive array of core services to fully support clinical research on the NCH and OSU campuses.